Clinical Practice Guidelines
Wilderness Medical Society Clinical Practice Guidelines on Anaphylaxis
The Wilderness Medical Society convened a panel to review the literature and develop evidence-based clinical practice guidelines on the treatment of anaphylaxis, with an emphasis on a field-based perspective. The review also included literature regarding the definition, epidemiology, clinical manifestations, and prevention of anaphylaxis. The increasing prevalence of food allergies in the United States raises concern for a corresponding rise in the incidence of anaphylaxis. Intramuscular epinephrine is the primary treatment for anaphylaxis and should be administered before adjunctive treatments such as antihistamines, corticosteroids, and inhaled β agonists.Recommendations on the Use of Epinephrine in Outdoor Education and Wilderness Settings
The Epinephrine Roundtable took place on July 27, 2008 during the 25th Annual Meeting of the Wilderness Medical Society (WMS) in Snowmass, CO. The panelists were, in alphabetical order: The WMS convened this roundtable to explore areas of consensus and uncertainty in the field treatment of anaphylaxis. There is a paucity of data that address the treatment of anaphylaxis in the wilderness. Anaphylaxis is a rare disease, with a sudden onset and drastic course that does not lend itself to study in randomized, controlled trials.
